Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

This study has been terminated.
(underfunding)
Sponsor:
Information provided by:
Central European Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT00294437
First received: February 20, 2006
Last updated: April 30, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2007
  Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)